- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- News News
- Join Join
Washington, D.C. -- Congressmen Earl Blumenauer (D-OR) and Sam Farr (D-CA) will join medical marijuana advocates, as well as multiple family members of imprisoned medical marijuana patients for a press conference in the District on Wednesday, September 18th, to urge Congress to restrict Department of Justice (DOJ) funding for enforcement in medical marijuana states. Patient advocates will be drawing attention to the more than $100,000 per day that the DOJ continues to spend on medical marijuana enforcement by staging a lively theatrical action during Wednesday's press conference in Washington, D.C.
Although Deputy Attorney General James Cole testified before the U.S. Senate last week that the DOJ would not go after individuals in compliance with state marijuana laws, the department's policy is non-binding and leaves much up to the discretion of U.S. Attorneys, many of whom have worked aggressively to undermine such state laws. Notably, after the DOJ memo was issued last month, U.S. Attorneys in at least three states (CA, MT and WA) have said publicly that they would continue to aggressively prosecute medical marijuana providers.
What: Theatrical press conference to urge Congress to restrict DOJ funding for medical marijuana enforcement in states that have adopted such laws
Featuring: Congressmen Earl Blumenauer (D-OR) and Sam Farr (D-CA), as well as several family members of imprisoned patients
When: Wednesday, September 18th at 10:30am
Where: House Budget Committee Hearing Room, 210 Cannon House Office Building, Washington, D.C.
"Patients need protection and legal access to medical marijuana, not more policy rhetoric from the Justice Department," said Steph Sherer, Executive Director of Americans for Safe Access (ASA), the country's leading medical marijuana advocacy group which is organizing Wednesday's press conference. "Patients have lost trust in the Obama Administration and are now looking for Congress to restrict its aggressive attempts to undermine state medical marijuana laws." The push to get Congress to take decisive action is part of ASA's Peace for Patients campaign.
Patients advocates are rallying Congressional support for HR 689, the States' Medical Marijuana Prevention Act, introduced in February by Congressman Blumenauer. HR 689 would restrict the DOJ from enforcing federal law against medical marijuana patients, as well as against pharmacies or other entities "authorized to distribute medical marijuana from obtaining, possessing, or distributing marijuana to authorized individuals." HR 689 also recommends that marijuana be reclassified for medical use under the Controlled Substances Act.
Wednesday's press conference comes on the same day that the U.S. Senate Judiciary Committee will hold hearings on "Reevaluating the Effectiveness of Federal Mandatory Minimum Sentences." The committee, which scheduled hearings after recent non-binding policy statements were made by the Obama Administration, will hear testimony from a panel of witnesses describing the need to reform federal mandatory minimum sentencing laws.
The press conference will feature several family members of medical marijuana prisoners serving mandatory minimum sentences, including Michigan patients Jerry and Jeremy Duval, California dispensary operator Aaron Sandusky, Montana cultivator Chris Williams, and one of his business partners Sherry Flor, whose husband Richard Flor died last year while serving a 5-year mandatory minimum sentence for his state-compliant cultivation.
Following Wednesday's press conference, advocates will be distributing to each Member of Congress a recently issued report on the economic and social costs of the Justice Department's war on medical marijuana being waged across the country. The "What's the Cost?" report was published by ASA in June and reveals that the Obama Administration has conducted more than 270 aggressive SWAT-style raids against state-compliant medical marijuana businesses and has spent more than $300 million over the past four years to do so.
HR 689, the States' Medical Marijuana Prevention Act: http://beta.congress.gov/bill/113th/house-bill/689
ASA's Peace for Patients campaign: http://peace4patients.org
# # #